CXCL8 and head and neck squamous cell carcinoma: In a recent study on the response of HNSCC patients to ICI across HPV signatures, Hill et al. (2023) reported that the HPV-negative HNSCC patients presented with increased levels of IL-8 (compared to pre-neoadjuvant ICI setting) in the scenario of no-response.